Synonyms: AAI101 | OCID-5090
Compound class:
Synthetic organic
Comment: Enmetazobactam is an extended-spectrum β-lactamase inhibitor. It is an N-methylated tazobactam derivative, under clinical development for use alongside β-lactam-containing antibacterial compounds to reduce their lactamase-induced degradation.
|
|
No information available. |
Summary of Clinical Use ![]() |
A Phase 3 study of cefepime + enmetazobactam in the treatment of complicated urinary tract infections has been completed (last update March 2020). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT03687255 | Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections | Phase 3 Interventional | Allecra | 1 |